TMCnet News
DSM Pharmaceutical Products and Metro Chapter of the Healthcare Businesswomen's Association to Host Panel [Manufacturing Close - Up](Manufacturing Close - Up Via Acquire Media NewsEdge) DSM Pharmaceutical Products and the Metro Chapter of the Healthcare Businesswomen's Association will host an panel examining market forces shaping the healthcare landscape and the collaborations that are accelerating the pace of health care innovation and development. According to a release, the event is May 21, at the DSM North America headquarters in Parsippany, N.J. It is part of an educational series offered by the HBA to offer women executives an opportunity to participate in thought leadership briefings, industry strategy discussions and networking. "We welcome the opportunity to host this HBA event, and further not only the discussion among global healthcare thought leaders, but also to provide a forum for women executives to network and support one another in the advancement of their careers and professional development," said Hugh Welsh, President DSM North America. "As healthcare costs continue to soar, it is imperative that we develop a more efficient and cost-effective model of healthcare delivery, and products that cure or prevent disease rather than merely treat ailments. Over the past decade, R&D productivity is declining, costs are rising while scientific output has stayed broadly flat," Alexander Wessels, President and CEO of DSM Pharmaceutical Products said. "In the wake of health reform, we are at a crucial moment in healthcare, and DSM is excited to host the brightest in biopharma in a call for increased partnership and knowledge-sharing." Speakers include Jo Pisani, Partner, Pharmaceuticals and Lifesciences Strategy, PricewaterhouseCoopers; Barbara Bush, CEO and Co-Founder, Global Health Corps; Paul Antinori, Senior Vice President and General Counsel, The Medicines Company; Lara Fontaine, Vice President, Worldwide R&D Strategy and Portfolio Solutions, Pfizer; Pam Bolton, Vice President, Membership and Advisory Services, GBCHealth; and Pamela Demain, Executive Director, Corporate Licensing, Merck. "At HBA, we believe it's critical to initiate discussion and increase connectivity between private and public players," said Kathleen Fitzpatrick, HBA Metro Chapter President. "Creative collaborations now take place in ways that would have been unthinkable a few years ago, and it's these partnerships that will be the catalyst to increased market efficiencies and a higher quality of patient care." ((Comments on this story may be sent to [email protected])) (c) 2013 ProQuest Information and Learning Company; All Rights Reserved. |